Universal Biotechnology (UB) was founded in 2011 with a clear purpose—to address the growing need for reliable, high-quality, and accessible biotechnology solutions in India.
The name UB itself defines our beliefs and philosophy. The DNA structure between “UB” in our logo represents our commitment to research-driven growth and our belief in reaching greater heights through quality, innovation, and scientific excellence.
Established by Mr. Deepak Negi and Mr. Manvir Rawat, Universal Biotechnology was built on transparency, integrity, and long-term commitment to the life-sciences community. From the beginning, the company aimed to bridge the gap between scientific innovation and real-world healthcare and research needs, enabling researchers, clinicians, and institutions to work with confidence.
As a leading biotechnology research product importer and consulting firm, we believe that no limits can stop us from achieving our goals. We stand firm on the pillars of strong business values, creativity, and innovative products to overcome every challenge that comes our way.
Universal Biotechnology was established as a proprietorship firm and entered the Indian life-sciences market with a focus on research-use biotechnology products. Early operations were centered on academic institutes, government laboratories, and diagnostic research labs.
The company developed strong relationships with scientists, principal investigators, lab managers, and procurement teams. The portfolio focused on ELISA kits, antibodies, proteins, and core research reagents, building early credibility through ethical pricing, timely deliveries, and responsive technical support.
Universal Biotechnology expanded its offerings across immunoassays, antibodies, and recombinant proteins. During this phase, the company began representing international biotechnology manufacturers, strengthening import logistics, documentation, and after-sales coordination.
Operations expanded across North, South, East, and West India, supported by a growing distributor and channel-partner network. Universal Biotechnology became increasingly recognized as a solution-oriented life-science partner, not just a supplier.
Internal systems were strengthened for order management, compliance, logistics, and customer support. Despite the challenges of the COVID-19 pandemic, the company ensured uninterrupted service, reinforcing long-term trust through consistency and reliability.
The company added specialized global principals and advanced product lines. In 2022, Universal Biotechnology was incorporated as Universal Biotechnology Private Limited, enabling structured growth, stronger corporate governance, and enhanced international credibility.
Groundwork was initiated for in-house and OEM manufacturing, particularly in RUO ELISA kits. Focus increased on quality control, documentation, and reproducibility standards, aligned with Make in India / Atmanirbhar Bharat initiatives. Today, Universal Biotechnology continues to expand into manufacturing, OEM solutions, and proprietary product development.
Universal Biotechnology’s growth has been shaped by navigating competitive markets, regulatory requirements, and operational complexity. Each challenge strengthened our focus on resilience, disciplined execution, and ethical conduct
What began as a distribution-driven enterprise has evolved into a structured organization with dedicated teams for sales, technical support, logistics, compliance, and customer engagement. Close collaboration with scientists and institutions has guided the expansion from core research reagents to a comprehensive portfolio of ELISA kits, antibodies, recombinant proteins, assay platforms, and customized research solutions.
Universal Biotechnology has made a meaningful impact on the life-sciences sector by delivering dependable, high-quality biotechnology solutions that support research, diagnostics, and scientific advancement.
The company actively collaborates with leading academic and government research institutions, including Jamia Hamdard University, VPCI (Vallabhbhai Patel Chest Institute - Virology Laboratories), and laboratories under DRDO, CSIR, and DBT, supporting completed, ongoing, and planned research initiatives.
Beyond direct customer engagement, Universal Biotechnology works closely with its distributor and supplier network, promoting technical awareness, ethical practices, and accurate product alignment—creating value across the entire biotechnology ecosystem.
Universal Biotechnology Private Limited is driven by a strong value framework known as QPECT, which defines our business conduct and decision-making:
Looking ahead, Universal Biotechnology aims to further strengthen its position by expanding technical expertise, manufacturing capabilities, and strategic collaborations across academia, industry, and government research institutions.
Our journey is not defined solely by past milestones, but by continuous progress, learning, and evolution. Each phase of growth lays the foundation for what lies ahead - reinforcing our commitment to innovation, integrity, and long-term value creation.
Guided by our founding vision - Achieving Trust with Honesty - Universal Biotechnology continues to move forward with confidence and purpose.
